Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed Scientists
JERUSALEM, April 4, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today a new paper co-authored by Oramed’s Chief Scientific Officer, Dr. Miriam Kidron, and Dr. Ehud Arbit. The paper, “Oral Insulin Delivery in a Physiologic Context” has been published […]